Cargando…
Preferred antiretroviral drugs for the next decade of scale up
Global commitments aim to provide antiretroviral therapy (ART) to 15 million people living with HIV by 2015, and recent studies have demonstrated the potential for widespread ART to prevent HIV transmission. Increasingly, countries are adapting their national guidelines to start ART earlier, for bot...
Autores principales: | Andrieux-Meyer, Isabelle, Calmy, Alexandra, Cahn, Pedro, Clayden, Polly, Raguin, Gilles, Katlama, Christine, Vitoria, Marco, Levin, Andrew, Lynch, Sharonann, Goemaere, Eric, Ford, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494169/ https://www.ncbi.nlm.nih.gov/pubmed/23010379 http://dx.doi.org/10.7448/IAS.15.2.17986 |
Ejemplares similares
-
The first decade of antiretroviral therapy in Africa
por: Ford, Nathan, et al.
Publicado: (2011) -
When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank
por: Vitoria, Marco, et al.
Publicado: (2017) -
Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years
por: Cohen, Rachel, et al.
Publicado: (2009) -
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings
por: Ford, Nathan, et al.
Publicado: (2011) -
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
por: Ford, Nathan, et al.
Publicado: (2020)